Skinvisible (SKVI) Capital Expenditures (2018 - 2025)

Skinvisible has disclosed Capital Expenditures across 7 years of filings, most recently posting -$1.0 for Q3 2025.

• Capital Expenditures for Q3 2025 came in at -$1.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.0 (changed 0.0% YoY), and the FY2025 annual result was $4086.0, down 55.67% from the prior year.
• Capital Expenditures came in at -$1.0 for Q3 2025 at Skinvisible, roughly flat from -$1.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $20414.0 in Q2 2021 to a low of -$1.0 in Q3 2023.
• The 4-year median for Capital Expenditures is $525.0 (2022), against an average of $4388.7.
• Peak annual rise in Capital Expenditures reached 47.9% in 2021, while the deepest fall reached 48.28% in 2021.
• Skinvisible's Capital Expenditures stood at $20414.0 in 2021, then sank by 97.43% to $525.0 in 2022, then plunged by 100.19% to -$1.0 in 2023, then changed by 0.0% to -$1.0 in 2025.
• The last three Capital Expenditures figures came in at -$1.0 (Q3 2025), -$1.0 (Q3 2023), and $8809.0 (Q2 2023), per Business Quant data.